title: [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
abstract: OBJECTIVE
  We report a retrospective study about vitrectomy in diabetic patients and the analysis of anatomical and functional results after surgery.
  
  
  METHODS
  We studied 66 eyes of 52 diabetic patients who underwent pars plana vitrectomy. Vitrectomy was performed for nonclearing intravitreous hemorrhage in 75% of eyes and for tractional macular retinal detachment in 14% of eyes.
  
  
  RESULTS
  After vitrectomy for intravitreous hemorrhage, visual acuity increased in 84% of eyes with more than 5/10 in half the cases. After vitrectomy for tractional retinal detachment, visual acuity increased or became stable in only 55% of eyes. The major complication of surgery was recurrence of intravitreous hemorrhage. A new surgery was not necessary in most cases. Neovascular glaucoma, phtysis, retinal detachment and cataract were the other complications of surgery.
  
  
  CONCLUSIONS
  Visual prognosis after vitrectomy performed in complicated diabetic retinopathy depends on the final macular function. Surgery for intravitreous hemorrhage without macular detachment produced in most of cases a good visual acuity. On the other hand, vitrectomy for tractional macular retinal detachment was followed by poor visual prognosis. After recurrent intravitreous hemorrhage, a new surgical procedure is possible with good visual results in most cases, even if several procedures are necessary.
authors.affiliation: Hôpital Edouard Herriot, Lyon.
authors.forename: O
authors.initials: O
authors.lastname: Bouchard
authors.forename: J C
authors.initials: JC
authors.lastname: Zech
authors.forename: C
authors.initials: C
authors.lastname: Trepsat
mesh_terms: D000328:Adult; D003930:Diabetic Retinopathy / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012008:Recurrence; D012163:Retinal Detachment / Q000209:etiology; D012189:Retrospective Studies; D014792:Visual Acuity; D014821:Vitrectomy / Q000009:adverse effects*; D014823:Vitreous Hemorrhage / Q000209:etiology